12 West Capital Management LP Atara Biotherapeutics, Inc. Transaction History

12 West Capital Management LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 16, 2021	SELL	$12.67 - $26.23 $2.01 Million - $4.16 Million	-158,700 Closed	0 $0
Q2 2018 Aug 14, 2018	SELL	$35.15 - $51.45 $703,000 - $1.03 Million	-20,000 Reduced 11.19%	158,700 $5.83 Million
Q1 2018 May 15, 2018	SELL	$18.0 - $48.35 $3.96 Million - $10.6 Million	-220,000 Reduced 55.18%	178,700 $6.97 Million
Q3 2017 Nov 14, 2017	BUY	$13.25 - $17.05 $5.28 Million - $6.8 Million	398,700	398,700 $6.6 Million

3.07M

Ticker ATRA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 94,362,304
Market Cap $763M
Description
Atara Biotherapeutics, Inc., an off-the-shelf T-cell immunotherapy company, develops treatments for patients with cancer, autoimmune, and viral diseases in the United States. It is developing tabelecleucel, a T-cell immunotherapy that is Phase 3 clinical trials for the treatment of epstein-barr virus (EBV) driven post-transplant lymphoproliferat...

Get notified when there are updates to the investment portfolio of 12 West Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on 12 West Capital Management LP with notifications on news.